Gold Nanoparticles as Radiosensitizers in Cancer Radiotherapy
Open accessThe DOI matches its Crossref record; 216 of the 216 references it cites were found in a registry or an index.
Abstract
The rapid development of nanotechnology offers a variety of potential therapeutic strategies for cancer treatment. High atomic element nanomaterials are often utilized as radiosensitizers due to their unique photoelectric decay characteristics. Among them, gold nanoparticles (GNPs) are one of the most widely investigated and are considered to be an ideal radiosensitizers for radiotherapy due to their high X-ray absorption and unique physicochemical properties. Over the last few decades, multi-disciplinary studies have focused on the design and optimization of GNPs to achieve greater dosing capability and higher therapeutic effects and highlight potential mechanisms for radiosensitization of GNPs. Although the radiosensitizing potential of GNPs has been widely recognized, its clinical translation still faces many challenges. This review analyses the different roles of GNPs as radiosensitizers in cancer radiotherapy and summarizes recent advances. In addition, the underlying mechanisms of GNP radiosensitization, including physical, chemical and biological mechanisms are discussed, which may provide new directions for the optimization and clinical transformation of next-generation GNPs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“High-Z nanoparticles enhance ROS generation by increasing local energy deposition and secondary electron emission, thereby amplifying free radical formation and oxidative stress following irradiation [9,10,86,88,102,103].”
From Nanoparticle-Mediated Radiosensitization in Breast Cancer: A Systematic Review of Preclinical Evidence and Translational Challenges (2026) · cites this paper as [9]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Nanoparticle-mediated radiosensitization has emerged as a promising strategy to enhance the therapeutic index of irradiation by combining physical dose amplification with biological, microenvironmental, and immunological modulation.”
From Nanoparticle-Mediated Radiosensitization in Breast Cancer: A Systematic Review of Preclinical Evidence and Translational Challenges (2026) · cites this paper as [9]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Early studies predominantly focused on high-atomic-number (high-Z) materials, including gold, silver, gadolinium, and hafnium-based nanoparticles, with the primary objective of maximizing radiation energy deposition and secondary electron generation [9,85,95,96].”
From Nanoparticle-Mediated Radiosensitization in Breast Cancer: A Systematic Review of Preclinical Evidence and Translational Challenges (2026) · cites this paper as [9]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“In general, materials with higher atomic numbers exhibit greater photoelectric interaction probabilities and therefore greater potential for secondary electron generation and local dose enhancement, particularly at kilovoltage photon energies [9,10,84,85,86].”
From Nanoparticle-Mediated Radiosensitization in Breast Cancer: A Systematic Review of Preclinical Evidence and Translational Challenges (2026) · cites this paper as [9]
The cited source says what the claim attributes to it.
In the citing paper
“High-atomic-number (high-Z) nanomaterials interact differently with kilovoltage and megavoltage photon beams, influencing photoelectric absorption, secondary electron generation, and local energy deposition—the principal physical mechanisms underlying nanoparticle-mediated radiotherapy enhancement [9,10,85,86,88].”
From Nanoparticle-Mediated Radiosensitization in Breast Cancer: A Systematic Review of Preclinical Evidence and Translational Challenges (2026) · cites this paper as [9]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Nanoparticle Mediated Tumor Vascular Disruption: A Novel Strategy in Radiation Therapy
Kunjachan, S., Detappe, A., Kumar, R., Ireland, T., Cameron, L., Biancur, D. E., Motto-Ros, V., Sancey, L., Sridhar, S., Makrigiorgos, G. M., et al. (2015) · Nano Letters · doi:10.1021/acs.nanolett.5b03073 · Cited by 152
RetractedCisplatin in cancer therapy: Molecular mechanisms of action
Dasari, S., & Bernard Tchounwou, P. (2014) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2014.07.025 · Cited by 5,537
New Perspectives in Cell Adhesion: RGD and Integrins
Ruoslahti, E., & Pierschbacher, M. D. (1987) · Science · doi:10.1126/science.2821619 · Cited by 4,865
Cedervall, T., Lynch, I., Lindman, S., Berggård, T., Thulin, E., Nilsson, H., Dawson, K. A., & Linse, S. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0608582104 · Cited by 3,281
Cell-cycle checkpoints and cancer
Kastan, M. B., & Bartek, J. (2004) · Nature · doi:10.1038/nature03097 · Cited by 2,836
Chitin and Chitosan Preparation from Marine Sources. Structure, Properties and Applications
Younes, I., & Rinaudo, M. (2015) · Marine Drugs · doi:10.3390/md13031133 · Cited by 2,562
Progress and challenges towards targeted delivery of cancer therapeutics
Rosenblum, D., Joshi, N., Tao, W., Karp, J. M., & Peer, D. (2018) · Nature Communications · doi:10.1038/s41467-018-03705-y · Cited by 2,220
The Tumour Microenvironment after Radiotherapy: Mechanisms of Resistance and Recurrence
Barker, H. E., Paget, J. T. E., Khan, A. A., & Harrington, K. J. (2015) · Nature Reviews Cancer · doi:10.1038/nrc3958 · Cited by 2,144
Nanoparticle PEGylation for Imaging and Therapy
Jokerst, J. V., Lobovkina, T., Zare, R. N., & Gambhir, S. S. (2011) · Nanomedicine · doi:10.2217/nnm.11.19 · Cited by 2,046
The use of gold nanoparticles to enhance radiotherapy in mice
Hainfeld, J. F., Slatkin, D. N., & Smilowitz, H. M. (2004) · Physics in Medicine and Biology · doi:10.1088/0031-9155/49/18/n03 · Cited by 1,638
Research works printed but not linked: 9
- Shrestha, 2016, Jacobs J Radiat Oncol, 3, 026
- Linam, 2015, Anticancer Res, 35, 2479
- Babaei, 2014, Nanomed J, 1, 211
- Mousavie Anijdan, 2013, Int J Mol Cell Med, 2, 118
- Eblan, 2013, Transl Cancer Res, 2, 320
- Jóźwiak, 2012, Postepy Hig Med Dosw, 66, 165
- Hu, 2015, Int J Nanomed, 10, 2065
- Kalmouni, 2019, Cell Mol Life Sci, 76, 2171
- Daniels, 2017, Biochem Biophys Rep, 10, 62
Cited by
Gold nanoparticles and gold nanorods in the landscape of cancer therapy
Kesharwani, P., Ma, R., Sang, L., Fatima, M., Sheikh, A., Abourehab, M. A. S., Gupta, N., Chen, Z.-S., & Zhou, Y. (2023) · Molecular Cancer · doi:10.1186/s12943-023-01798-8 · Cited by 337
Gold nanoparticles (GNPs) in biomedical and clinical applications: A review
Anik, M. I., Mahmud, N., Al Masud, A., & Hasan, M. (2022) · Nano Select · doi:10.1002/nano.202100255 · Cited by 228
An Overview on Gold Nanorods as Versatile Nanoparticles in Cancer Therapy
Nejabat, M., Samie, A., Ramezani, M., Alibolandi, M., Abnous, K., & Taghdisi, S. M. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.01.009 · Cited by 122
Prospects of nanoparticle-based radioenhancement for radiotherapy
Gerken, L. R. H., Gerdes, M. E., Pruschy, M. N., & Herrmann, I. K. (2023) · Materials Horizons · doi:10.1039/d3mh00265a · Cited by 123
Nanoparticles in cancer diagnosis and treatment: Progress, challenges, and opportunities
Rashidi, N., Davidson, M., Apostolopoulos, V., & Nurgali, K. (2024) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2024.105599 · Cited by 118
Nanomedicine Combats Drug Resistance in Lung Cancer
Zheng, X., Song, X.-H., Zhu, G., Pan, D., Li, H., Hu, J., Xiao, K., Gong, Q., Gu, Z., Luo, K., et al. (2023) · Advanced Materials · doi:10.1002/adma.202308977 · Cited by 103
Nanoparticles advanced from preclinical studies to clinical trials for lung cancer therapy
Liu, Y., Cheng, W., Xin, H., Liu, R., Qinqi, W., Cai, W., Peng, X., Yang, F., & Xin, H. (2023) · Cancer Nanotechnology · doi:10.1186/s12645-023-00174-x · Cited by 98
The Promise of Nanoparticles-Based Radiotherapy in Cancer Treatment
Haque, M., Shakil, M. S., & Mahmud, K. M. (2023) · Cancers · doi:10.3390/cancers15061892 · Cited by 102
Guan, Y., Zhang, W., Mao, Y., & Li, S. (2024) · Molecular Cancer · doi:10.1186/s12943-024-02161-1 · Cited by 91
Qin, X., Yang, C., Xu, H., Zhang, R., Zhang, D., Tu, J., Guo, Y., Niu, B., Kong, L., & Zhang, Z. (2021) · Small · doi:10.1002/smll.202103984 · Cited by 85
Alle, M., Sharma, G., Lee, S. H., & Kim, J. (2022) · Journal of Nanobiotechnology · doi:10.1186/s12951-022-01402-z · Cited by 86
Abrishami, A., Bahrami, A. R., Nekooei, S., Saljooghi, A. S., & Matin, M. M. (2024) · Communications Biology · doi:10.1038/s42003-024-06043-6 · Cited by 86
Nejad, M. S., Najafabadi, N. S., Aghighi, S., Pakina, E. N., & Zargar, M. (2022) · Molecules · doi:10.3390/molecules27041181 · Cited by 82
Radiosensitization Effect of Gold Nanoparticles in Proton Therapy
Cunningham, C., de Kock, M., Engelbrecht, M., Miles, X., Slabbert, J. P., & Vandevoorde, C. (2021) · Frontiers in Public Health · doi:10.3389/fpubh.2021.699822 · Cited by 79
Targeted regulation of autophagy using nanoparticles: New insight into cancer therapy
Paskeh, M. D. A., Entezari, M., Clark, C. J., Zabolian, A., Ranjbar, E., Farahani, M. V., Saleki, H., Sharifzadeh, S. O., Far, F. B., Ashrafizadeh, M., et al. (2021) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2021.166326 · Cited by 76
Kumar, K., Rani, V., Mishra, M., & Chawla, R. (2022) · Current Research in Pharmacology and Drug Discovery · doi:10.1016/j.crphar.2022.100103 · Cited by 76
Gold Nanoparticles in Nanomedicine: Unique Properties and Therapeutic Potential
Eker, F., Akdaşçi, E., Duman, H., Bechelany, M., & Karav, S. (2024) · Nanomaterials · doi:10.3390/nano14221854 · Cited by 78
Nanomaterial-Based Molecular Imaging in Cancer: Advances in Simulation and AI Integration
Chow, J. C. L. (2025) · Biomolecules · doi:10.3390/biom15030444 · Cited by 77
Anti-Tumor Strategies of Photothermal Therapy Combined with Other Therapies Using Nanoplatforms
Xu, R., Wang, S., Guo, Q., Zhong, R., Chen, X., & Xia, X. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17030306 · Cited by 72
High Stability Au NPs: From Design to Application in Nanomedicine
Zhang, M., Shao, S., Yue, H., Wang, X., Zhang, W., Chen, F., Zheng, L., Xing, J., & Qin, Y. (2021) · International Journal of Nanomedicine · doi:10.2147/ijn.s322900 · Cited by 70
Aptamer-conjugated gold nanoparticles and their diagnostic and therapeutic roles in cancer
Deng, G., Zha, H., Luo, H., & Yi, Z. (2023) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2023.1118546 · Cited by 65
Khan, M. A., Singh, D., Ahmad, A., & Siddique, H. R. (2021) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2021.105892 · Cited by 63
New Frontiers in Colorectal Cancer Treatment Combining Nanotechnology with Photo- and Radiotherapy
Freitas, S. C., Sanderson, D., Caspani, S., Magalhães, R., Cortés‐Llanos, B., Granja, A., Reis, S., Belo, J. H., Azevedo, J., Gómez‐Gaviro, M. V., et al. (2023) · Cancers · doi:10.3390/cancers15020383 · Cited by 64
Greene, M. K., Johnston, M. C., & Scott, C. J. (2021) · Cancers · doi:10.3390/cancers13246175 · Cited by 61
Nanoparticles: Attractive tools to treat colorectal cancer
Younis, N. K., Roumieh, R., Bassil, E. P., Ghoubaira, J. A., Kobeissy, F. H., & Eid, A. H. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2022.08.006 · Cited by 63
Slama, Y., Ah-Pine, F., Khettab, M., Arcambal, A., Begue, M., Dutheil, F., & Gasque, P. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241713511 · Cited by 57
Clinical Viability of Boron Neutron Capture Therapy for Personalized Radiation Treatment
Skwierawska, D., Balcerzyk, M., López-Valverde, J. A., & Leal, A. (2022) · Cancers · doi:10.3390/cancers14122865 · Cited by 52
Enzyme-mimic catalytic activities and biomedical applications of noble metal nanoclusters
Pan, X., Yao, Y., Zhang, M., Yuan, X. F., Yao, Q., & Hu, W. (2024) · Nanoscale · doi:10.1039/d4nr00282b · Cited by 57
Cao, L., Yang, Y., Zheng, Y., Cheng, W., Chen, M., Wang, T., Mu, C., Wu, M., & Liu, B. (2024) · Advanced Materials · doi:10.1002/adma.202401017 · Cited by 51
Zhou, R., Gong, J., Deng, X., Shen, L., Wu, S., Fan, H., & Liu, L. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.117404 · Cited by 59
Advances of Nanomedicine in Radiotherapy
Liu, W., Chen, B., Zheng, H., Xing, Y., Chen, G., Zhou, P., Qian, L., & Min, Y. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13111757 · Cited by 55
Colak, B., & Ertas, Y. N. (2024) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.3c17024 · Cited by 50
Wu, Z., Cheng, K., Shen, Z., Lu, Y., Wang, H., Wang, G., Wang, Y., Yang, W., Sun, Z., Guo, Q., et al. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1048211 · Cited by 54
Biomolecule-protected gold nanoclusters: synthesis and biomedical applications
Hao, D., Zhang, X., Su, R., Wang, Y., & Qi, W. D. (2023) · Journal of Materials Chemistry B · doi:10.1039/d3tb00651d · Cited by 46
Application of nano‐radiosensitizers in combination cancer therapy
Varzandeh, M., Sabouri, L., Mansouri, V., Gharibshahian, M., Beheshtizadeh, N., Hamblin, M. R., & Rezaei, N. (2023) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10498 · Cited by 48
Chargari, C., Maury, P., Texier, M., Genestie, C., Morice, P., Bockel, S., Gouy, S., Bâ, M. B., Achkar, S., Lux, F., et al. (2024) · ACS Nano · doi:10.1021/acsnano.3c12537 · Cited by 48
Critical parameters to translate gold nanoparticles as radiosensitizing agents into the clinic
Moloudi, K., Khani, A., Najafi, M., Azmoonfar, R., Azizi, M., Nekounam, H., Sobhani, M., Laurent, S., & Samadian, H. (2023) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1886 · Cited by 43
Gold Nanoparticles Contact with Cancer Cell: A Brief Update
Bloise, N., Strada, S., Dacarro, G., & Visai, L. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23147683 · Cited by 46
ROS-generating nanoplatforms as selective and tunable therapeutic weapons against cancer
Foglietta, F., Serpe, L., & Canaparo, R. (2023) · Discover Nano · doi:10.1186/s11671-023-03939-w · Cited by 49
Ultrasound-Responsive Nanocarriers for Breast Cancer Chemotherapy
Ayana, G., Ryu, J., & Choe, S. (2022) · Micromachines · doi:10.3390/mi13091508 · Cited by 46
Nanoparticle-Mediated Hyperthermia and Cytotoxicity Mechanisms in Cancer
Bala, V.-M., Lampropoulou, D. I., GRAMMATIKAKI, S., Kouloulias, V., Lаgopati, N., Aravantinos, G., & Gazouli, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms25010296 · Cited by 41
Kang, K., Wu, Y., Yao, Z., & Lü, Y. (2023) · Cancer Letters · doi:10.1016/j.canlet.2023.216239 · Cited by 43
Albumin-Modified Gold Nanoparticles as Novel Radiosensitizers for Enhancing Lung Cancer Radiotherapy
Chen, Y., Liu, S., Liao, Y., Yang, H., Chen, Z., Hu, Y., Fu, S., & Wu, J. (2023) · International Journal of Nanomedicine · doi:10.2147/ijn.s398254 · Cited by 40
Self-citationGuerra, D. B., de Oliveira, E. M. N., Sonntag, A. R., Sbaraine, P., Fay, A. P., Morrone, F. B., & Papaléo, R. M. (2022) · Scientific Reports · doi:10.1038/s41598-022-13368-x · Cited by 38
Bemidinezhad, A., Mirzavi, F., Gholamhosseinian, H., Gheybi, F., & Soukhtanloo, M. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.121495 · Cited by 40
Bhattacharjee, B., Farhana, S. A., Rynjah, D., Hussain, S. M., Bora, S. C., Pegu, P., Sahu, R. K., & Khan, J. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1174330 · Cited by 35
Intricate subcellular journey of nanoparticles to the enigmatic domains of endoplasmic reticulum
Girigoswami, K., Pallavi, P., & Girigoswami, A. (2023) · Drug Delivery · doi:10.1080/10717544.2023.2284684 · Cited by 36
Entezari, M., Abad, G. G. Y., Sedghi, B., Ettehadi, R., Asadi, S., Beiranvand, R., Haratian, N., Karimian, S. S., Jebali, A., Khorrami, R., et al. (2023) · Environmental Research · doi:10.1016/j.envres.2023.115673 · Cited by 36
Ahmed, N. K., Abbady, A. G. E., Elhassan, Y. A., & Said, A. H. (2023) · BioNanoScience · doi:10.1007/s12668-023-01085-2 · Cited by 36
Tremi, I., Havaki, S., Georgitsopoulou, S., Lаgopati, N., Georgakilas, V. I., Gorgoulis, V. G., & Georgakilas, A. G. (2021) · Nanomaterials · doi:10.3390/nano11040859 · Cited by 33
Emerging trends in the application of gold nanoformulations in colon cancer diagnosis and treatment
Aldahhan, R., Almohazey, D., & Khan, F. A. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2021.11.008 · Cited by 39
Taheri, A., Khandaker, M. U., Moradi, F., & Bradley, D. A. (2023) · Radiation Physics and Chemistry · doi:10.1016/j.radphyschem.2023.111146 · Cited by 35
Monte Carlo Simulations in Nanomedicine: Advancing Cancer Imaging and Therapy
Chow, J. C. L. (2025) · Nanomaterials · doi:10.3390/nano15020117 · Cited by 32
Emerging plasmonic nanoparticles and their assemblies for cancer radiotherapy
Wu, Y., Zhu, K., Zhang, X., Du, W. T., Song, J., & Yang, H. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.114710 · Cited by 32
CT and MRI Imaging of Theranostic Bimodal Fe3O4@Au NanoParticles in Tumor Bearing Mice
Lipengolts, A. A., Finogenova, Y. А., Skribitsky, V. А., Shpakova, K. E., Anaki, A., Motiei, M., Semkina, A. S., Abakumov, M. A., Smirnova, A. V., Grigorieva, Е. Y., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms24010070 · Cited by 36
Application of Gold Nanoparticles as Radiosensitizer for Metastatic Prostate Cancer Cell Lines
Soares, S., de Faria, I. C. J., Aires, F., Monteiro, A., Pinto, G., Sales, M. G. F., Correa‐Duarte, M. A., Guerreiro, S. G., & Fernandes, R. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24044122 · Cited by 31
Transport of nanocarriers to brain for treatment of glioblastoma multiforme: Routes and challenges
Trivedi, S., Bhoyar, V. T., Akojwar, N., & Belgamwar, V. S. (2023) · Nano Trends · doi:10.1016/j.nwnano.2023.100005 · Cited by 31
Peptide-Hydrogel Nanocomposites for Anti-Cancer Drug Delivery
Haghighi, F. H., Binaymotlagh, R., Fratoddi, I., Chronopoulou, L., & Palocci, C. (2023) · Gels · doi:10.3390/gels9120953 · Cited by 32
Lu, D., Li, W., Tan, J., Li, Y., Mao, W., Zheng, Y., Yang, M., Wang, J., Wang, W., Wang, S., et al. (2024) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.4c09825 · Cited by 29
Application of quantum dots in cancer diagnosis and treatment: Advances and perspectives
Li, M., Huang, Y. H., Shen, C., Wang, Y., Lin, Y., Wang, Z., Chen, N., & Luo, Y. (2024) · Nano Research · doi:10.26599/nr.2025.94907163 · Cited by 30
Appidi, T., China, D., Ștefan, G.-R., Moreau, M., Mao, S., Velarde, E., Toyang, N. J., Lowe, H. I. C., Rengan, A. K., Ding, K., et al. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02266-1 · Cited by 33
Gold Nanoparticles Enhancing Generation of ROS for Cs-137 Radiotherapy
Tsai, S., Lo, C.-Y., Yu, S.-Y., Chen, G. T. Y., Huang, H., Wang, L., & Liaw, J. (2022) · Nanoscale Research Letters · doi:10.1186/s11671-022-03761-w · Cited by 31
Benkhaled, S., Peters, C., Jullian, N., Arsenijevic, T., Navez, J., Gestel, D. V., Moretti, L., Laethem, J. V., & Bouchart, C. (2023) · Cancers · doi:10.3390/cancers15030768 · Cited by 30
Zhang, A., & Gao, L. (2023) · International Journal of Nanomedicine · doi:10.2147/ijn.s436268 · Cited by 32
Zhang, J., Zou, H., Gan, S., He, B., Huang, J. C., Peng, C., Lam, J. W. Y., Zheng, L., & Tang, B. Z. (2021) · Advanced Functional Materials · doi:10.1002/adfm.202108199 · Cited by 28
Bromma, K., Santos, N. D., Barta, I., Alexander, A., Beckham, W., Krishnan, S., & Chithrani, D. B. (2022) · Scientific Reports · doi:10.1038/s41598-022-17752-5 · Cited by 28
Zhou, R., Zhao, D., Beeraka, N. M., Wang, X., Lu, P., Song, R., Chen, K., & Liu, J. (2022) · Metabolites · doi:10.3390/metabo12100943 · Cited by 31
Bustanji, Y. K., Taneera, J., Semreen, M. H., Abu‐Gharbieh, E., El‐Huneidi, W., Faris, M. E., Alzoubi, K. H., Soares, N. C., Albustanji, B., Abuhelwa, A. Y., et al. (2023) · OpenNano · doi:10.1016/j.onano.2023.100164 · Cited by 27
Nanotheranostics-based Management of Head and Neck Cancer
Chavda, V. P., Balar, P. C., & Patel, S. B. (2023) · Nanotheranostics · doi:10.7150/ntno.81724 · Cited by 28
Khorshid, M., Varshosaz, J., Rostami, M. R., Haghiralsadat, F., Akbari, V., & Khorshid, P. (2023) · Biomaterials Advances · doi:10.1016/j.bioadv.2023.213591 · Cited by 26
Radiation nanomedicines for cancer treatment: a scientific journey and view of the landscape
Reilly, R. M., Georgiou, C. J., Brown, M. K., & Cai, Z. (2024) · EJNMMI Radiopharmacy and Chemistry · doi:10.1186/s41181-024-00266-y · Cited by 26
Xu, N., Wang, J., Liu, L., & Gong, C. (2023) · Chinese Chemical Letters · doi:10.1016/j.cclet.2023.109225 · Cited by 25
Sayed, Z. S., Hieba, E. M., Batakoushy, H. A., Rashdan, H. R. M., Ismail, E., Elkatlawy, S. M., & Elzwawy, A. (2024) · RSC Advances · doi:10.1039/d4ra06992g · Cited by 26
Yogo, K., Misawa, M., Shimizu, H., Kitagawa, T., Hirayama, R., Ishiyama, H., Yasuda, H., Kametaka, S., & Takami, S. (2022) · Nanomaterials · doi:10.3390/nano12050771 · Cited by 25
Mechanisms of Nanoscale Radiation Enhancement by Metal Nanoparticles: Role of Low Energy Electrons
Zheng, Y., & Sanche, L. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24054697 · Cited by 27
Javid, H., Oryani, M. A., Rezagholinejad, N., Hashemzadeh, A., & Karimi‐Shahri, M. (2024) · Journal of Materials Chemistry B · doi:10.1039/d4tb00281d · Cited by 25
Enhancing Proton Therapy Efficacy Through Nanoparticle-Mediated Radiosensitization
Ma, J., Shen, H., & Mi, Z. (2024) · Cells · doi:10.3390/cells13221841 · Cited by 23
Schmidt, R. M., Hara, D., Vega, J. D., Abuhaija, M. B., Tao, W., Dogan, N., Pollack, A. S., Ford, J. C., & Shi, J. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14102205 · Cited by 25
Tarantino, S., Caricato, A. P., Rinaldi, R., Capomolla, C., & Matteis, V. D. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15020500 · Cited by 26
Chemoradiotherapy and nanomedicine: Drug mechanisms and delivery systems
Molinaro, M., Skrodzki, D., & Pan, D. (2024) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1984 · Cited by 28
Metal‐Protein Hybrid Materials: Unlocking New Frontiers in Biomedical Applications
Pan, Y., Zhao, H., Huang, W., Liu, S., Qi, Y., & Huang, Y. (2025) · Advanced Healthcare Materials · doi:10.1002/adhm.202404405 · Cited by 24
Cruz-Nova, P., Ancira-Cortez, A., Ferro‐Flores, G., Ocampo‐García, B., & Gibbens-Bandala, B. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14051095 · Cited by 22
Nanomedicine-based adjuvant therapy: a promising solution for lung cancer
Xu, Y., Hsu, J. C., Xu, L., Chen, W., Cai, W., & Wang, K. (2023) · Journal of Nanobiotechnology · doi:10.1186/s12951-023-01958-4 · Cited by 21
Jackson, N., Hill, I., Alhussan, A., Bromma, K., Morgan, J., Abousaida, B., Zahra, Y., Mackeyev, Y., Beckham, W., Herchko, S. M., et al. (2023) · Cancer Nanotechnology · doi:10.1186/s12645-023-00228-0 · Cited by 21
Kolyvanova, M. A., Belousov, A. V., Krusanov, G. A., Isagulieva, A. K., Morozov, K. V., Kartseva, M. E., Salpagarov, M. K., Krivoshapkin, P. V., Дементьева, О. В., Rudoy, V. M., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22116030 · Cited by 20
Santiago, C. A., & Chow, J. C. L. (2023) · Applied Sciences · doi:10.3390/app13084916 · Cited by 20
Tremi, I., Havaki, S., Georgitsopoulou, S., Terzoudi, G. I., Lykakis, I. N., Iliakis, G. E., Georgakilas, V. I., Gorgoulis, V. G., & Georgakilas, A. G. (2022) · Cancers · doi:10.3390/cancers14205086 · Cited by 21
Sharma, Y., Mahar, R., Chakraborty, A., & Nainwal, N. (2023) · Tuberculosis · doi:10.1016/j.tube.2023.102417 · Cited by 19
Gan, N., Wakayama, C., Inubushi, S., Kunihisa, T., Mizumoto, S., Baba, M., Tanino, H., & Ooya, T. (2021) · ACS Applied Bio Materials · doi:10.1021/acsabm.1c01149 · Cited by 19
Marques, A., Belchior, A., Silva, F., Marques, F., Campello, M. P. C., Pinheiro, T., Santos, P. M. P., Santos, L. S., Matos, A., & Paulo, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23095279 · Cited by 21
Recent Advances in Metal-Based NanoEnhancers for Particle Therapy
Chuang, Y.-C., Wu, P., Shen, Y., Kuo, C., Wang, W., Chen, Y., Lee, H., & Chiou, J. (2023) · Nanomaterials · doi:10.3390/nano13061011 · Cited by 23
Self-citationMusielak, M., Boś-Liedke, A., Piwocka, O., Kowalska, K., Markiewicz, R., Szymkowiak, B., Bakun, P., & Suchorska, W. M. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15030862 · Cited by 18
Nanomaterials Based on Functional Polymers for Sensitizing Cancer Radiotherapy
Lin, J., Yin, M., Liu, X., Meng, F., & Luo, L. (2022) · Macromolecular Rapid Communications · doi:10.1002/marc.202200194 · Cited by 18
Luo, Y. (2025) · Frontiers in Nanotechnology · doi:10.3389/fnano.2025.1603334 · Cited by 22
Zhang, R., Jia, M., Lv, H., Li, M., Ding, G., Cheng, G., & Li, J. (2024) · Journal of Nanobiotechnology · doi:10.1186/s12951-023-02279-2 · Cited by 18
Carbone, G. G., Mariano, S., Gabriele, A., Cennamo, S., Primiceri, V., Aziz, M. R., Panzarini, E., & Calcagnile, L. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17020176 · Cited by 19
Vlastou, E., Kougioumtzopoulou, A., Platoni, K., Georgakopoulos, I., Lаgopati, N., Kouloulias, V., & Zygogianni, A. (2025) · Cancers · doi:10.3390/cancers17050899 · Cited by 17
Nanomedicine Approaches for Autophagy Modulation in Cancer Therapy
Mahri, S., Villa, R., Shiau, Y., Tang, M., Racacho, K. J., Zong, Q., Chowdhury, S., Hua, T., Godinez, F., Birkeland, A. C., et al. (2025) · Small Science · doi:10.1002/smsc.202400607 · Cited by 23
Microbiome-targeted nanoplatforms and engineering approaches in breast cancer therapy
Sabeel, Z., & Zhao, Y. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02456-x · Cited by 21
Klębowski, B., Stec, M., Depciuch, J., Panek, A., Krzempek, D., Komenda, W., Gałuszka-Bulaga, A., Pajor-Świerzy, A., Baran, J., & Parlińska‐Wojtan, M. (2022) · Cancers · doi:10.3390/cancers14235899 · Cited by 17
Metadata
- Authors
- Chen, Y., Yang, J., Fu, S., & Wu, J.
- Affiliations
- Southwest Medical University (CN)
- Corresponding author
- Fu, Shaozhi
- Venue
- International Journal of Nanomedicine
- Publisher
- Informa UK Limited
- Published
- 2020-11
- Volume
- Volume 15
- Pages
- 9407-9430
- ISSN
- 1176-9114 (ISSN-L)
- 1178-2013
- PMC
- PMC7699443
- OpenAlex
- W3108978735
- Cited by
- 319
- References
- 216
- Citations by year
- 2026: 46 · 2025: 65 · 2024: 62 · 2023: 79 · 2022: 45 · 2021: 22
- FWCI
- 5.11
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Nanomedicine (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Dove Medical Press (Taylor and Francis Group) (submittedVersion, cc-by-nc)
- Funders
- Servier
- Southwest Medical University (2013LZLY-J40, 14JC0144)
- Topics
- Physical Sciences › Physics and Astronomy › Radiation › Radiation Therapy and Dosimetry
- Physical Sciences › Physics and Astronomy › Radiation › Advanced Radiotherapy Techniques
- Physical Sciences › Engineering › Biomedical Engineering › Nanoplatforms for cancer theranostics
- Keywords
- gold nanoparticles, radiosensitizers, cancer radiotherapy, radiosensitization mechanism, X-ray absorption, nanoparticle design, clinical translation, nanomedicine
- MeSH terms
- Gold, Humans, Neoplasms, Radiation-Sensitizing Agents, Nanomedicine, Metal Nanoparticles
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.



